Sfoglia per AUTORE
GHIDINI M
Collezione AOU Novara

  

Items : 9

2025
AOU San Luigi di Orbassano
AOU Novara

Wakelee H; Garassino M; Peters S; Takada K; Naqash AR; Torri V; Hejleh TA; Ferrara R; Aerts JGJV; Aboubakar Nana F; Dingemans AM; Biello F; Rogado J; Moliner L; Beninato T; Lo Russo G; Servetto A; Mezquita L; Gorría T; Minuti G; Bennati C; Tonini G; Cortinovis DL; Agustoni F; Majem M; Baena J; Macerelli M; Monnet I; O'Reilly D; et alii...

Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line Chemotherapy. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2025 Feb 17;31(4):707-718. doi: 10.1158/1078-0432.CCR-24-0924.
2025
AOU Novara

Ghidini M; Hahne JC; Senti C; Heide T; Proszek PZ; Shaikh R; Carter P; Hubank M; Trevisani F; Garrone O; Cappelletti MR; Generali D; Cattaneo M; Gnocchi N; Donati G; Gobbi A; Grizzi G; Lampis A; Elghadi R; Tanzi G; Tomasello G; Ratti M; Pinato DJ; Fassan M; Vlachogiannis G; Sottoriva A; Cortellini A; Passalacqua R; Valeri N; et alii...

Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2024 May 15;30(10):2140-2159. doi: 10.1158/1078-0432.CCR-23-2748.
2024
AOU Novara

Hedayat S; Cascione L; Cunningham D; Schirripa M; Lampis A; Hahne JC; Tunariu N; Hong SP; Marchetti S; Khan K; Fontana E; Angerilli V; Delrieux M; Nava Rodrigues D; Procaccio L; Rao S; Watkins D; Starling N; Chau I; Braconi C; Fotiadis N; Begum R; Guppy N; Howell L; Valenti M; Cribbes S; Kolozsvari B; Kirkin V; Lonardi S; et alii...

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer. in Nature medicine / Nat Med. 2023 Mar;29(3):605-614. doi: 10.1038/s41591-023-02240-8. Epub 2023 Mar 2.
2023
ASL Torino 4
AOU Novara

Tamburini E; Petrillo A; Gobba SM; Graham J; Longarini R; Garrone O; Zanaletti N; De Tursi M; Parisi A; Libertini M; Morelli C; Cergnul M; Depetris I; Ratti M; Fenocchio E; Zoratto F; Thomas A; Iveson T; Messina C; Pavarana M; Ross P; Rodriquenz MG; Stavraka C; Rosati G; Antonuzzo L; Mazzuca F; Merz V; Gelsomino F; Berardi R; et alii...

Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2023 Jul 14;29(14):2714-2724. doi: 10.1158/1078-0432.CCR-22-3116.
2023
AOU Novara

Cortellini A; D'Alessio A; Cleary S; Buti S; Bersanelli M; Bordi P; Tonini G; Vincenzi B; Tucci M; Russo A; Pantano F; Russano M; Stucci LS; Sergi MC; Falconi M; Zarzana MA; Santini D; Spagnolo F; Tanda ET; Rastelli F; Giorgi FC; Pergolesi F; Giusti R; Filetti M; Lo Bianco F; Marchetti P; Botticelli A; Gelibter A; Siringo M; et alii...

2023
AOU Novara

Giacomelli L; Papa S; Giordano G; Dadduzio V; Gadaleta-Caldarola G; Paolillo R; Giannini EG; Pieri G; Mega A; Granito A; Marzi L; Masi G; Cesario S; Rancatore G; Cabibbo G; Cocuzza C; Russello M; Gallo P; Silletta M; Daniele B; Federico P; Pirisi M; Burlone ME; di Costanzo GG; Tortora R; Ramai D; Sacco R; Renzulli M; Maida M; et alii...

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. in Journal of hematology & oncology / J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Russo A; Porzio G; Tiseo M; Russano M; Ficorella C; Addeo A; Banna GL; Friedlaender A; Spinelli GP; Metro G; Migliorino MR; Passiglia F; Ricciardi S; Zoratto F; Pecci F; Di Marino P; Mansueto G; De Tursi M; Tuzi A; Gori S; Della Gravara L; Macerelli M; Rastelli F; Chiari R; Gelibter A; Marchetti P; Antonuzzo L; Mazzoni F; et alii...

PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort. in Journal of translational medicine / J Transl Med. 2021 Jun 24;19(1):270. doi: 10.1186/s12967-021-02937-9.
2021
AOU Novara

Santini D; Zeppola T; Russano M; Citarella F; Anesi C; Buti S; Tucci M; Russo A; Sergi MC; Adamo V; Stucci LS; Bersanelli M; Mazzaschi G; Spagnolo F; Rastelli F; Giorgi FC; Giusti R; Filetti M; Marchetti P; Botticelli A; Gelibter A; Siringo M; Ferrari M; Marconcini R; Vitale MG; Nicolardi L; Chiari R; Ghidini M; Nigro O; et alii...

Integrating Biological Advances Into the Clinical Management of Breast Cancer Related Lymphedema. in Frontiers in oncology / Front Oncol. 2020 Apr 2;10:422. doi: 10.3389/fonc.2020.00422. eCollection 2020.
2020
AOU Novara

Invernizzi M; Lopez G; Michelotti A; Venetis K; Sajjadi E; De Mattos-Arruda L; Ghidini M; Runza L; de Sire A; Boldorini R; Fusco N;